BENZENO SHARON Insider Trading
Get the latest insider transactions of BENZENO SHARON. BENZENO SHARON is Chief Business Development Off in Adaptive Biotechnologies Corp ($ADPT) and SVP, Drug Discovery in Adaptive Biotechnologies Corp ($ADPT). Discover the current value of BENZENO SHARON shares.
Address: C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1551 EASTLAKE AVE E STE 200 SEATTLE 98102WA
BENZENO SHARON is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | Chief Business Development Off, SVP, Drug Discovery | 22,894 |
Insider Trading Transactions of BENZENO SHARON
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Mar 08 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 0.00 | 22,894 | 0 | 22,894 |
| Mar 08 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 43.68 | 57,234 | 2,499,981 | 57,234 |
| Feb 17 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 31.71 | 16,250 | 515,288 | 16,250 |
| Feb 17 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 63.42 | 5,022 | 318,495 | 11,228 |
| Feb 17 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 64.59 | 1,700 | 109,803 | 9,528 |
| Feb 17 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 65.29 | 9,528 | 622,083 | 0 |
| Feb 17 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 31.71 | 16,250 | 515,288 | 48,750 |
| Feb 03 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 2,604 | 17,056 | 2,604 |
| Feb 03 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 2,604 | 17,056 | 5,208 |
| Feb 03 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 7.27 | 1,562 | 11,356 | 6,770 |
| Feb 03 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 55.61 | 6,470 | 359,797 | 300 |
| Feb 03 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 56.41 | 300 | 16,923 | 0 |
| Feb 03 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 2,604 | 17,056 | 23,438 |
| Feb 03 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 2,604 | 17,056 | 52,084 |
| Feb 03 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 7.27 | 1,562 | 11,356 | 35,938 |
| Jan 20 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.27 | 417 | 2,615 | 417 |
| Jan 20 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 69.00 | 417 | 28,773 | 0 |
| Jan 20 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.27 | 417 | 2,615 | 1,250 |
| Jan 06 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 2,604 | 17,056 | 2,604 |
| Jan 06 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 2,604 | 17,056 | 5,208 |
| Jan 06 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 7.27 | 1,563 | 11,363 | 6,771 |
| Jan 06 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 56.12 | 2,209 | 123,969 | 4,562 |
| Jan 06 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 57.82 | 3,800 | 219,716 | 762 |
| Jan 06 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 58.63 | 495 | 29,022 | 267 |
| Jan 06 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 59.46 | 267 | 15,876 | 0 |
| Jan 06 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 2,604 | 17,056 | 26,042 |
| Jan 06 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 2,604 | 17,056 | 54,688 |
| Jan 06 2021 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 7.27 | 1,563 | 11,363 | 37,500 |
| Dec 23 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.27 | 417 | 2,615 | 417 |
| Dec 23 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 59.14 | 417 | 24,661 | 0 |
| Dec 23 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.27 | 417 | 2,615 | 1,667 |
| Dec 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 2,604 | 17,056 | 2,604 |
| Dec 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 2,604 | 17,056 | 5,208 |
| Dec 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 7.27 | 1,562 | 11,356 | 6,770 |
| Dec 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 48.20 | 3,077 | 148,311 | 3,693 |
| Dec 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 49.43 | 3,693 | 182,545 | 0 |
| Dec 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 2,604 | 17,056 | 28,646 |
| Dec 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 2,604 | 17,056 | 57,292 |
| Dec 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 7.27 | 1,562 | 11,356 | 39,063 |
| Nov 23 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.27 | 416 | 2,608 | 416 |
| Nov 23 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 48.86 | 416 | 20,326 | 0 |
| Nov 23 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.27 | 416 | 2,608 | 2,084 |
| Nov 04 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 2,605 | 17,063 | 2,605 |
| Nov 04 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 2,604 | 17,056 | 5,209 |
| Nov 04 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 7.27 | 1,563 | 11,363 | 6,772 |
| Nov 04 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 45.47 | 5,698 | 259,088 | 1,074 |
| Nov 04 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 46.14 | 1,074 | 49,554 | 0 |
| Nov 04 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 2,605 | 17,063 | 31,250 |
| Nov 04 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 2,604 | 17,056 | 59,896 |
| Nov 04 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 7.27 | 1,563 | 11,363 | 40,625 |
| Oct 20 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.27 | 417 | 2,615 | 417 |
| Oct 20 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 51.25 | 417 | 21,371 | 0 |
| Oct 20 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.27 | 417 | 2,615 | 2,500 |
| Oct 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 2,604 | 17,056 | 2,604 |
| Oct 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 2,605 | 17,063 | 5,209 |
| Oct 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 7.27 | 1,562 | 11,356 | 6,771 |
| Oct 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 48.46 | 5,878 | 284,848 | 893 |
| Oct 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 49.26 | 893 | 43,989 | 0 |
| Oct 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 2,604 | 17,056 | 33,855 |
| Oct 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 2,605 | 17,063 | 62,500 |
| Oct 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 7.27 | 1,562 | 11,356 | 42,188 |
| Sep 23 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.27 | 417 | 2,615 | 417 |
| Sep 23 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 45.51 | 417 | 18,978 | 0 |
| Sep 23 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.27 | 417 | 2,615 | 2,917 |
| Sep 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 2,604 | 17,056 | 2,604 |
| Sep 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 2,604 | 17,056 | 5,208 |
| Sep 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 7.27 | 1,563 | 11,363 | 6,771 |
| Sep 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 41.28 | 6,471 | 267,123 | 300 |
| Sep 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 41.75 | 300 | 12,525 | 0 |
| Sep 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 2,604 | 17,056 | 36,459 |
| Sep 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 2,604 | 17,056 | 65,105 |
| Sep 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 7.27 | 1,563 | 11,363 | 43,750 |
| Aug 19 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.27 | 416 | 2,608 | 416 |
| Aug 19 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 41.57 | 416 | 17,293 | 0 |
| Aug 19 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.27 | 416 | 2,608 | 3,334 |
| Aug 05 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 2,604 | 17,056 | 2,604 |
| Aug 05 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 2,604 | 17,056 | 5,208 |
| Aug 05 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 7.27 | 1,562 | 11,356 | 6,770 |
| Aug 05 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.32 | 417 | 2,635 | 7,187 |
| Aug 05 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 40.00 | 7,187 | 287,480 | 0 |
| Aug 05 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 2,604 | 17,056 | 39,063 |
| Aug 05 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 2,604 | 17,056 | 67,709 |
| Aug 05 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 7.27 | 1,562 | 11,356 | 45,313 |
| Aug 05 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.32 | 417 | 2,635 | 0 |
| Jul 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.27 | 417 | 2,615 | 417 |
| Jul 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 40.00 | 417 | 16,680 | 0 |
| Jul 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.27 | 417 | 2,615 | 3,750 |
| Jul 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 2,604 | 17,056 | 2,604 |
| Jul 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 2,604 | 17,056 | 5,208 |
| Jul 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 7.27 | 1,563 | 11,363 | 6,771 |
| Jul 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 47.17 | 5,571 | 262,784 | 1,200 |
| Jul 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 48.13 | 1,200 | 57,756 | 0 |
| Jul 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 2,604 | 17,056 | 41,667 |
| Jul 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 2,604 | 17,056 | 70,313 |
| Jul 02 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 7.27 | 1,563 | 11,363 | 46,875 |
| Jul 01 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.32 | 417 | 2,635 | 417 |
| Jul 01 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 47.42 | 417 | 19,774 | 0 |
| Jul 01 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.32 | 417 | 2,635 | 417 |
| Jun 30 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.32 | 417 | 2,635 | 417 |
| Jun 30 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 47.42 | 417 | 19,774 | 0 |
| Jun 30 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.32 | 417 | 2,635 | 417 |
| Jun 23 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.27 | 417 | 2,615 | 417 |
| Jun 23 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 45.00 | 417 | 18,765 | 0 |
| Jun 23 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.27 | 417 | 2,615 | 4,167 |
| Jun 05 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 2,604 | 17,056 | 2,604 |
| Jun 05 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 2,604 | 17,056 | 5,208 |
| Jun 05 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 7.27 | 1,562 | 11,356 | 6,770 |
| Jun 05 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 40.00 | 6,770 | 270,800 | 0 |
| Jun 05 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 2,604 | 17,056 | 43,271 |
| Jun 05 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 2,604 | 17,056 | 72,917 |
| Jun 05 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 7.27 | 1,562 | 11,356 | 48,438 |
| May 28 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.32 | 416 | 2,629 | 416 |
| May 28 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 42.00 | 416 | 17,472 | 0 |
| May 28 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.32 | 416 | 2,629 | 834 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 1.98 | 60,000 | 118,800 | 60,000 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.32 | 18,750 | 118,500 | 78,750 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.27 | 15,416 | 96,658 | 94,166 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 78,125 | 511,719 | 172,291 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 49,479 | 324,087 | 221,770 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 7.27 | 25,000 | 181,750 | 246,770 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 40.00 | 246,770 | 9,870,800 | 0 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 1.98 | 60,000 | 118,800 | 0 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.32 | 18,750 | 118,500 | 1,250 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.27 | 15,416 | 96,658 | 4,584 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 78,125 | 511,719 | 45,875 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 49,479 | 324,087 | 75,521 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 7.27 | 25,000 | 181,750 | 50,000 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 1.98 | 60,000 | 118,800 | 60,000 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.32 | 18,750 | 118,500 | 78,750 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.27 | 15,416 | 96,658 | 94,166 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 78,125 | 511,719 | 172,291 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 6.55 | 49,479 | 324,087 | 221,770 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Buy | 7.27 | 25,000 | 181,750 | 246,770 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Sell | 40.00 | 246,770 | 9,870,800 | 0 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 1.98 | 60,000 | 118,800 | 0 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.32 | 18,750 | 118,500 | 1,250 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.27 | 15,416 | 96,658 | 4,584 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 78,125 | 511,719 | 45,875 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 6.55 | 49,479 | 324,087 | 75,521 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | Chief Business Develo ... | Option Exercise | 7.27 | 25,000 | 181,750 | 50,000 |
| Feb 18 2020 | ADPT | Adaptive Biotechnologies ... | BENZENO SHARON | SVP, Drug Discovery | Option Exercise | 31.71 | 65,000 | 2,061,150 | 65,000 |